MedNet21 CME Podcast

MedNet21 is an on-line CME Webcast produced by the Center for Continuing Medical Education at The Ohio State University Wexner Medical Center. Our focus is to address professional practice gaps and issues important to primary care physicians. This is a free "podcast version" of our webcast produced through our MedNet21 CME series. Each year we provide 40 weekly CME webcasts for our 10 month season, and programs are accessible 24 hours a day, 7 days a week from anywhere in the world. You can watch MedNet21 webcasts on-line to get CME credit today. Each post-test costs $25. You can also become a hospital subscriber to give physicians at your hospital an opportunity to earn CME credit for free. To view our webcasts, navigate to the following website: https://ccme.osu.edu/WebCastSearch.aspx.

Rank #1: Multiple Myeloma.
Today on MedNet21, we're going to discuss Multiple Myeloma.

Rank #2: Medical Marijuana.
Today on MedNet21, we're going to discuss Medical Marijuana.

PeerView Internal Medicine CME/CNE/CPE Audio Podcast

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Rank #1: Loren del Mar Pena, MD, PhD - Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease

Rank #2: Edward J. Fox, MD, PhD - Current Status and Future Directions in the Treatment of Multiple Sclerosis: What Are the Key Learnings From Stockholm?.
Go online to PeerView.com/UYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in neurology discusses new and late-breaking data on current and emerging treatments for multiple sclerosis from the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2019). Upon completion of this activity, participants should be better able to: Employ recently presented data related to approved disease-modifying therapies when treating patients with multiple sclerosis, Examine new data on the efficacy, safety, and tolerability of emerging disease-modifying therapies for the treatment of multiple sclerosis, Recognize the potential clinical utility of investigational disease-modifying therapies in the future management of multiple sclerosis

Yale Medicine

A selected collection of Internal Medicine conferences and grand rounds from the Yale Primary Care Internal Medicine Residency Program hosted at Waterbury Hospital, Yale-New Haven Hospital, and the Yale School of Medicine.

Rank #1: Serious Bacterial Infections in HIV-Infected Adults.
Presented by Dr. Majid Sadigh during the ongoing Makerere Univ./Yale Univ. Collaboration. Selected topics include infections with Rhodococcus, Mycobacteria, Bartonella, and Salmonella.

Rank #2: Pneumocystis Jiroveci Pneumonia.
Presented by Dr. Majid Sadigh in Kampala, Uganda as a part of the collaboration between Makerere University and Yale University

PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Rank #1: Ruchi S. Gupta, MD, MPH, and Robert Sidbury, MD, MPH - A Closer Look at the Atopic Dermatitis Patient Journey: Effective Management Approaches Across the Age and Disease Spectrum.
Go online to PeerView.com/XHY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in dermatology and pediatric primary care discuss the management of patients with atopic dermatitis. A patient also joins the discussion to provide unique perspectives on living with atopic dermatitis and interacting with healthcare providers. Upon completion of this activity, participants should be better able to: Diagnose atopic dermatitis in individual patients based on recognition of clinical manifestations and application of current diagnostic criteria and guidelines, Describe the mechanisms of action and clinical profiles of new and emerging topical and systemic therapies for atopic dermatitis, Select appropriate treatments for patients with atopic dermatitis based on current guideline recommendations, the safety and efficacy of available treatment options, comorbidities, and burden of disease, Employ shared decision-making approaches to create individualized treatment plans for atopic dermatitis, Implement patient/caregiver education strategies to improve adherence to atopic dermatitis treatment (eg, managing application-site pain associated with topical therapies) and assess the effects of treatment on patient quality of life

Rank #2: Stewart J. Tepper, MD, FAHS - Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention.
Go online to PeerView.com/DCR860 to view the entire program with slides. Migraine, a common neurovascular brain disorder, represents a severe and widespread health problem. In recent years a number of novel therapies for the acute treatment and prevention of migraine have been developed. These include centrally acting serotonin (5HT1F) agonists and therapies directed against the calcitonin gene-related peptide (CGRP) ligand and its receptor. In this activity, based on a recent live symposium held in Denver, Colorado, experts in neurology briefly review how migraine can be identified in clinical practice, discuss the latest data on emerging therapies for the acute treatment of migraine, assess current data on approved and emerging anti-CGRP monoclonal antibodies for migraine prevention, and highlight key considerations for using these therapies in clinical practice. Upon completion of this activity, participants will be able to: Apply established screening tools and criteria for migraine diagnosis in clinical practice, Identify data on the efficacy, safety, and tolerability of established and emerging therapeutics for the acute treatment of migraine, Cite updated evidence on available and emerging therapies for the prevention of migraine, Employ strategies to integrate emerging therapies for acute treatment and headache prevention into personalized management plans for patients with migraine if/when these agents are approved in the future.

PodMed – Johns Hopkins Medicine Podcasts

Rank #1: PodMed – Week of September 4, 2017.
This week’s topics include the right medications for a subset of people with heart disease, the PURE study, inflammation and heart disease, and the impact of neighborhoods on cardiovascular disease. Program notes: 0:47 PURE study 1:47 Fats and animal protein associated with lower mortality 2:47 Goes against years of research 3:31 Inflammation and CVD 4:32 […]

Rank #2: PodMed – Week of September 18, 2017.
This week’s topics include hospital factors relative to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market. Program notes: 0:32 Cost of R and D versus profit in new drugs 1:32 Took 7.3 years 2:35 Reaping in sales far outstrips R and D 3:32 R […]

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Rank #1: Stewart J. Tepper, MD, FAHS - Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?.
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?

Rank #2: Anthony J. Mancini, MD, FAAP, FAAD - Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the Differences Between Children, Adolescents, and Adults.
Go online to PeerView.com/YGP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this infographic-based activity, an expert dermatologist discusses the burden and clinical manifestations of atopic dermatitis (AD) in children, adolescents, and adults and offers insight into the best practices to improve the care of young patients with this condition. Upon completion of this activity, participants should be better able to: Recognize the burden of disease and unmet needs experienced by pediatric and adolescent patients with atopic dermatitis (AD) and their caregivers, Identify the differences in clinical manifestations and differential diagnoses between children, adolescents, and adults with AD, Discuss the mechanism of action and the latest clinical data related to the efficacy and safety of currently available and emerging treatments for pediatric and adolescent AD, Employ an individualized, proactive approach to the long-term treatment of children and adolescents with AD.

Louisville Lectures Internal Medicine Lecture Series Podcast

Internal medicine lectures focused on clinically and board relevant topics from faculty and guest lecturers with the University of Louisville Internal Medicine Department.

Rank #1: Hypertensive Crisis with Dr. Lorrel Brown.
Dr. Lorrel Brown discusses the Hypertensive Crisis by first defining hypertension. She then defines hypertensive crisis as having severely elevated blood pressure with end-organ damage. After, she discusses the pathophysiology of end organ damage along with the different treatment approaches for hypertensive crisis. Finally, she finishes her presentation with a few case reports. Some items in this lecture may have come from the lecturer’s personal academic files or have been cited in-line or at the end of the lecture. For more information, see our citation page.Disclaimers©2016 LouisvilleLectures.org

Rank #2: Sodium, Potassium, Diuretics with Dr. Lederer.
Dr. Eleanor Lederer addresses sodium and potassium regulation including mechanisms of diuretics.  She presents a basic approach to addressing cases and analyzing serum and urine electrolytes in the context of presentation. Dr. Lederer is an Associate Professor of Medicine at the University of Lousiville. She is the Chief of the Division of Nephrology and the Program Director for the Nephrology and Kidney Disease Fellowship. Her faculty profile can be found here.

The Rounds Table

The Rounds Table is a free recurring medical podcast covering the latest and most important research from major medical journals. It is intended for all practicing healthcare professionals and aims to to help them keep up to date in the care of their patients.

Rank #1: What the Heart Wants: Takotsubo Cardiomyopathy and Cardiovascular Benefits of Empagliflozen.
The “broken heart syndrome” – not always caused by a broken heart? A multi-national, multi-centered observational study on takotsubo cardiomyopathy found that physical triggers are more common than emotional triggers, patients present predominantly with chest pain, ECG changes, and troponin elevation. The study also generated surprising hypotheses about what medications have long-term benefit for these patients. This is the first time a glucose lowering drug has been shown to decrease cardiovascular mortality in Type 2 diabetes! A randomized control trial found empagliflozen had significant cardiovascular benefits in Type 2 diabetics with established cardiovascular disease. For every 38 patients treated with empagliflozen for three years, one would be saved from death. Is this impressive result due to better glycemic control, or another effect of the drug? Let us know what you think about the new Clinical Encounters segment! Follow us on Twitter @roundstable. The papers 1. Takotsubo cardiomyopathy: http://www.nejm.org/doi/full/10.1056/NEJMoa1406761 2. Cardiovascular benefits of empagliflozen: http://www.nejm.org/doi/full/10.1056/NEJMoa1504720 Good Stuff 1. Water on mars: http://news.sciencemag.org/space/2015/10/mars-once-hosted-lakes-flowing-water 2. #dayofdiabetes: http://tobesugarfree.com/2015/04/14/7-reasons-why-you-should-participate-in-dayofdiabetes-tomorrow/ Music Credits (Creative Commons) In your Robotic Heart – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/in-your-robotic-heart Drive – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/drive-fresh-upbeat-pop-background-music Swingin’ Jazz – Nicolai Heidlas ‎https://m.soundcloud.com/nicolai-heidlas/jazz-blues-background-music “Searching for Jupiter” – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/searching-for-jupiter All tracks have been modified for the purposes of this podcast. The post What the Heart Wants: Takotsubo Cardiomyopathy and Cardiovascular Benefits of Empagliflozen appeared first on Healthy Debate.

Rank #2: Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV.
Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It’s hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, for many conditions, the optimal duration of a course of antibiotics has not yet been established! So let’s try shortening it to make it easier. Kieran and Jay discuss a study which examines whether, in patients with community acquired pneumonia, 5 days of treatment with antibiotics is as safe and effective as longer courses of treatment. Even with major advances in HIV treatment and management, there were 2 million cases of HIV transmission in 2014. How can this number be lowered? Kieran and Jay discuss a study which assessed early antiretroviral therapy as prevention for HIV-1 transmission. It wouldn’t be The Rounds Table without a Good Stuff segment: What does the race to create a Zika vaccine look like? How did an Aboriginal community first encounter Creutzfeldt-Jacob disease? Listen to find out! Rate us on iTunes! Follow us on Twitter @roundstable The Papers 1. Duration of antibiotics in Community-Acquired Pneumonia: http://archinte.jamanetwork.com/article.aspx?articleid=2536189 2. Antiretroviral therapy for prevention of HIV transmission: http://www.nejm.org/doi/full/10.1056/NEJMoa1600693#t=article Good Stuff 1. Zika vaccination: http://www.newyorker.com/magazine/2016/08/22/the-race-for-a-zika-vaccine 2. Kuru and CJD: http://www.npr.org/sections/thesalt/2016/09/06/482952588/when-people-ate-people-a-strange-disease-emerged Music Credits (Creative Commons) In your Robotic Heart – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/in-your-robotic-heart Drive – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/drive-fresh-upbeat-pop-background-music Vintage Dream – Nicolai Heidlas https://soundcloud.com/nicolai-heidlas/vintage-dream-loungejazzy-background-music All tracks have been modified for the purposes of this podcast. The post Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV appeared first on Healthy Debate.

The University of Iowa Department of Emergency Medicine

This podcast is the didactic lecture audio and procedure video from the University of Iowa Department of Emergency Medicine.

Rank #1: EM Lecture: The Pathophysiology of Shock.
Dr Dickson's famous annual lecture to the first year medical students on the physiology of shock.

Rank #2: Abdominal Pain.
A Case Based Approach to Acute Abdominal Pain in the ER

Primary Care Today

Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care.

Rank #1: Preventing a Prescription for Abuse: Alternatives to Opioid Narcotics for Pain After Surgery .
Host: Brian P. McDonough, MD, FAAFP Each year more than 70 million post-surgical patients are prescribed opioids. Research shows 1 in 15 will go on to use the medications long term, potentially putting them at risk for addiction and overdose. Host Dr. Brian McDonough sits down with Dr. Susan Downey, a board-certified plastic surgeon, to talk about opioid abuse and what alternative prescription options are available instead of narcotics.

Rank #2: Addressing Allergies in Primary Care .
Host: Brian P. McDonough, MD, FAAFP Allergic complaints in primary care settings are sometimes more than they appear, raising the importance of good diagnostic criteria for other underlying problems. Joining Dr. Brian McDonough for an in-depth discussion of allergy in the general and specialized practice levels is Dr. Will Sheppard, a board certified Otolaryngologist/ Head and Neck Surgeon and a Fellow of the American Academy of Otolaryngic Allergy. His practice includes medical and surgical management of ear, nose, and throat disorders of pediatric and adult patients.

Emergency Medical Minute

Our near daily podcasts move quickly to reflect current events, are inspired by real patient care, and speak to the true nature of what it’s like to work in the Emergency Room or Pre-Hospital Setting. Each medical minute is recorded in a real emergency department, by the emergency physician or clinical pharmacist on duty – the ER is our studio and everything is live.

Rank #1: Deep Dive #8: Wintertime Wilderness Medicine.
Author: John Winkler, M.D. Dr. Winkler shares his knowledge of wilderness medicine and provides insight on how to prevent and treat conditions such as hypothermia, frostbite and sun blindness. More importantly, he gives us tips on how to stay safe while doing our favorite wintertime activities!

Rank #2: Aortic Dissection.
What's the difference between an Aortic Dissection and an Aortic Aneurysm?

JAMA Medical News: Interviews and Summaries

Timely and engaging discussions about advances in clinical research and practice, biomedical science, public health, and health policy.

Rank #1: “Is There a Doctor on the Plane?”.
In this Medical News podcast, frequent traveler Rachel Zang, MD, talks about her experiences helping ill patients aboard commercial airline flights and discusses what physicians should know about in-flight medical emergencies. Read the article: "Is There a Doctor on the Plane?"

Rank #2: Cardiologist Trades Stem Cells for Cell-Based Meat.
Beef and poultry grown from animal cells rather than sourced from whole animals could be the future of meat production, a cardiologist-turned-biotech entrepreneur says in this Medical News podcast.

Annals of Internal Medicine Podcast

Issue highlights and interviews from Annals of Internal Medicine.

Rank #1: Atrial fibrillation.
Contemporary management of atrial fibrillation; interview with Tristram Bahnson, MD, of Duke University Medical Center; plus a summary of all the issue's articles.

Rank #2: Jan 15, 2008.
Multidrug resistant MRSA infection in men who have sex with men; an interview with study coauthors Binh Diep, PhD and Henry Chambers, MD, of the University of California San Francisco; and a systematic review of evidence for improving end-of-life care. Plus a summary of all the articles in this week's issue.

Hospital and Internal Medicine Podcast

Intended for the medical professional who enjoys learning for the sake of it. Dr. Porat is a practicing Colorado Hospitalist and Board Certified in Internal Medicine.

Rank #1: Pneumonia - Part 1.
Does the patient really have pneumonia? Differential diagnosis and mimics are considered in this common clinical problem. Dive deeper into how microbes and the immune system interact in lower respiratory infections.

Rank #2: Pulmonary Embolism - part 1.
The topics covered are D-Dimer testing, false positive over-diagnosis of PE on CT scanning, the ADJUST-PE study, and clinical signs and symptoms of a pulmonary embolism.

Family Medicine & Pharmacy Podcast

priority topics for family medicine and community pharmacy

Rank #1: Pediatric Fever.
The bulk of this episode is based on the UK NICE guideline: Feverish illness in children under 5, published in 2013. http://guidance.nice.org.uk/CG160 The guideline covers: Thermometers and the detection of fever Clinical assessment of the child with fever (using the traffic light system) Management by remote assessment Management by the non-paediatric practitioner Management by the paediatric specialist (investigations summarized below) Antipyretic interventions The Traffic Light System in assessing risk for serious infection This assessment tool takes into consideration color/appearance, activity, respiratory, circulation and hydration, and “other” parameters. For each parameter, their associated signs and symptoms are assigned a color code: “green” (low risk), “amber” (intermediate risk) and “red” (high risk). The table can be found here. Age-appropriate investigations for pediatric fever Once the risk for serious infection is determined, the following investigation should be performed: Age CBC diff BC CRP UA/UC LP CXR Stool culture <1mo yes yes yes yes yes if indicated if indicated 1-3mo yes yes yes yes if unwell, or WBC >15 or <5M/mL if indicated if indicated >=3mo, RED yes yes yes yes yes yes if indicated >=3mo, AMBER yes yes yes yes if <1yr if fever >39 and WBC >20 if indicated >=3mo, GREEN no no no yes no no if indicated And at the same time, empiric parenteral antibiotic coverage for meningitis (3rd generation cephalosporin plus ampicillin/amoxicillin) should be started if LP is indicated. The post Pediatric Fever appeared first on Family Pharm Podcast.

Rank #2: A Fib 5: Antithrombotics.
Antiplatelets: ASA Clopidogrel Anticoagulants: Warfarin Apixaban Dabigatran Rivaroxaban Clotting Cascade: Clotting Factor Song, by Emily Anne Nagler: Twelve, eleven, nine, it’s clotting factor time 8 and 9 to 10a 5, that’s how we stay alive Don’t forget to say: the tissue factor way 7 to 7a helps 10 go to 10a Then 2 to thrombin, and 1 to fibrin And that’s how it ends The post A Fib 5: Antithrombotics appeared first on Family Pharm Podcast.